+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Neodymium:YAG laser and brachytherapy in the management of inoperable bronchogenic carcinoma

Neodymium:YAG laser and brachytherapy in the management of inoperable bronchogenic carcinoma

Annals of Thoracic Surgery 50(2): 190

Neodymium:yttrium-aluminum garnet (Nd:YAG) laser therapy and endobronchial brachytherapy are useful modalities in the palliation of inoperable bronchogenic carcinoma. From 1983 to 1989, 218 patients underwent a total of 371 procedures involving endobronchial brachytherapy, Nd:YAG laser therapy, or both. Group 1 consisted of 130 patients who received Nd:YAG laser therapy. Group 2 consisted of 67 patients who had endobronchial brachytherapy only. Group 3 comprised 21 patients who underwent combined endobronchial brachytherapy and Nd:YAG laser therapy. All patients had received or were receiving concurrent radiotherapy. Three late deaths occurred in group 1, and 1 death occurred in group 2. More than 80% of patients achieved a good to excellent result. When applicable, we now use combined Nd:YAG laser therapy and endobronchial brachytherapy as part of the initial management of inoperable non-small cell bronchogenic carcinoma. A detailed analysis of these patients is given.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 040780121

Download citation: RISBibTeXText

PMID: 1696452

DOI: 10.1016/0003-4975(90)90731-k

Related references

Neodymium yag laser pulmonary lumpectomy for stage 1 bronchogenic carcinoma. Thorax 45(10): 805, 1990

Laser photodynamic therapy for inoperable bronchogenic squamous carcinoma. Quarterly Journal of Medicine 64(243): 565-581, 1987

Survival analysis following neodymium yag laser photoresection for primary bronchogenic carcinoma. Chest 92(2 Suppl.): 136S, 1987

Management of the patient with inoperable bronchogenic carcinoma. Medical Clinics of North America 51(2): 563-572, 1967

Clinical studies of endoscopic neodymium yttrium aluminum garnet laser surgery in bronchogenic carcinoma. Journal of Tokyo Medical College 43(1): 123-132, 1985

Newer palliative measures in the management of inoperable bronchogenic carcinoma. Diseases of the Chest 21(5): 491-512, 1952

Intermediate dose rate remote afterloading brachytherapy and laser for intraluminal control of bronchogenic carcinoma. Chest 94(1 Suppl.): 84S, 1988

Ureteroscopic management of transitional cell carcinoma of the ureter using the neodymium:YAG laser. Lasers in Surgery and Medicine 13(6): 625-628, 1993

Neodymium-Yag laser in the treatment of inoperable tumors of the trachea and the large bronchi. Minerva Chirurgica 43(22): 1915-1918, 1988

The value of radiotherapy in inoperable bronchogenic carcinoma. Practitioner 180(1080): 695-700, 1958

The value of radiotherapy in inoperable bronchogenic carcinoma. International Journal of Radiation Oncology*biology*physics 4(Supp-S2): 75-0, 1978

Chemotherapy of inoperable bronchogenic carcinoma. Indian Journal of Chest Diseases and Allied Sciences 27(3): 175-189, 1985

Treatment of inoperable bronchogenic carcinoma. Oesterreichische Zeitschrift fuer Onkologie 4(5/6): 106-110, 1977

Angiography of inoperable bronchogenic carcinoma. Wiener Klinische Wochenschrift 85: Suppl 9:1-11, 1973

Hexamethylmelamine in inoperable bronchogenic carcinoma. New York State Journal of Medicine 72(4): 477-480, 1972